title: Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients.
authors.affiliation: Sandoz Pharma, Ltd, Biopharmaceutic Department, Basel, Switzerland.
authors.forename: L
authors.initials: L
authors.lastname: Vernillet
authors.forename: J M
authors.initials: JM
authors.lastname: Kovarik
authors.forename: R
authors.initials: R
authors.lastname: Freiburghaus
authors.forename: P
authors.initials: P
authors.lastname: Schaub
authors.forename: E A
authors.initials: EA
authors.lastname: Mueller
authors.forename: W
authors.initials: W
authors.lastname: Niederberger
authors.forename: H
authors.initials: H
authors.lastname: Zehender
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001711:Biotransformation; D002214:Capsules; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D016572:Cyclosporine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D005260:Female; D005780:Gelatin; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
chemical_list: D002214:Capsules; D016572:Cyclosporine; D005780:Gelatin